On Sept. 14, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.